Gland Pharma

Nifty Pharma index today, Nifty Pharma down, Indian pharma stocks fall

Pharma stocks crack, Nifty Pharma Index slips over 2% as Trump unveils 100% tariff: 3 key factors investors must watch

Nifty Pharma index drops over 2% after Trump unveils 100% tariff on drug imports – see which stocks are most…

September 26, 2025 11:50 IST

3 ‘Buy’ recommendations by Motilal Oswal, with up to 18% upside potential

Motilal Oswal tips L&T, Gland Pharma, and Kotak Bank for up to 18% returns—see why these stocks could boost your…

September 25, 2025 14:25 IST

From SBI, Gensol Engineering, United Breweries to IRCON International- Here are 9 stocks to watch

Stocks to watch today, May 21: GIFT Nifty indicates a subdued start for domestic indices. Here are top stocks to…

May 21, 2025 06:38 IST

Gland Pharma, fourth quarter, Q4 results, profit, revenue, EBITDA, dividend, investment, US market, collaborations, manufacturing

Gland Pharma Q4 Results: Net profit drops by 3% at Rs 186.54 crore on revenue decline on US market

Gland Pharma posted a 3 per cent decline in consolidated net profit to Rs 186.54 crore in the fourth quarter…

May 20, 2025 18:30 IST

USFDA gives nod to Gland Pharma’s generic formulation to treat glaucoma

According to IQVIA, the product had US sales of approximately USD 111.6 million for the twelve months ending December 2023.

December 3, 2024 14:40 IST

Q1FY25 results, Gland Pharma, Gland Pharma results, Gland Pharma Q1FY25 results, healthcare news, pharma news,

Q1FY25 results: Gland Pharma’s revenue rose by 16 percent to Rs. 1401.7 crore

Q1FY25 Results: The company also presented an outlook for Q2FY25 and said that lower activity levels are expected due to…

August 6, 2024 18:28 IST

Gland Pharma gets USFDA approval for its breast cancer drug

The Product has US sales of approximately $92 million for twelve months ending in February 2024, according to IQVIA.

April 8, 2024 17:27 IST

gland pharma, gland pharma quarterly results, gland pharma q3 results, industry

Gland Pharma posts Q3 profit fall on soaring employee costs

Gland Pharma’s total expenses jumped nearly 89% to Rs 12.99 billion, dragged by a more than three-fold climb in its…

February 14, 2024 17:59 IST

Gland Pharma stock jumps 20% today after revenue grows 41% on-year in Q1; should you buy, sell or hold GLAND?

Gland Pharma shares hit the upper circuit today after the company’s revenue grew 41% on-year to Rs 1,208.6 crore in…

August 8, 2023 12:16 IST

Glenmark, Glenmark pharmaceuticals, diabetes, blood sugar, healthcare news, pharma news,

Gland Pharma’s net profit falls 72 percent to Rs. 79 crore in Q4FY23

According to the company’s statement, core markets of US, Europe, Canada, Australia, and New Zealand accounted for 70% of revenue…

May 18, 2023 19:23 IST

viral infections, OPD cases, seasonal ailments, seasonal flu, health news,

Gland Pharma’s net profit declines 15 percent; Shares hit 52-week low

According to the company’s statement, its margin on earnings before interest, taxes, depreciation, and amortisation slipped to 35 percent from…

January 24, 2023 12:32 IST

Artificial Intelligence, AI, healthcare, healthtech, low-cost drugs, healthcare news,

Gland Pharma shares fall 4% on Cenexi acquisition report; should you buy, hold or sell?

Gland Pharma’s Singapore subsidiary Gland Pharma International PTE has entered into an agreement to acquire 100% of France-based contract development…

November 30, 2022 12:11 IST

Gland Pharma share price tanks 12% to hit 52-week low on weak Q1 results; stock may top Rs 3000 to rally 24%

At least two research and brokerage firms — Motilal Oswal Financial Services and YES Securities are bullish on Gland Pharma…

Updated: July 21, 2022 16:01 IST

Investor – Gland Pharma: Maintain ‘buy’; margins to be steady

Gland has a relatively limited launched portfolio in the Rest-of-World Market and India, which will expand to provide growth opportunities.

March 29, 2022 01:30 IST

Related News

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar linking and KYC rules explained

F-1 visa denied for applicant after single question at US Consulate

UK immigration new rules, Skilled Worker visa changes, Graduate visa months, UK visa reforms, High Potential Individual route, UK student visa rules, UK Visa English requirement

UK announces major changes in immigration rules for overseas students and foreign workers

Mappls vs Google Maps: 5 standout features of India’s homegrown navigation app

Business tycoon Anand Mahindra shared a serene glimpse of Palakkad, Kerala, calling it “the perfect escape” from modern life’s chaos.

‘Not a tourist destination, nor…’: Anand Mahindra calls Kerala’s Palakkad village ‘the perfect escape’ from modern life

Midwest IPO: Why is GMP signalling caution ahead of D’Street debut? Check listing date

Market16 min ago

Midwest, a leading company in the mining and construction industry, has successfully completed its IPO and will be listed on Indian bourses on October 24. The IPO was oversubscribed by 92.36 times, with strong demand from all investor categories. The company plans to use the Rs 451 crore raised for future growth, despite a slight decrease in the grey market premium.

View all shorts